SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-16-675312
Filing Date
2016-08-08
Accepted
2016-08-08 17:12:06
Documents
4
Group Members
ALLERGAN EQUICO B.V.WARNER CHILCOTT LTDWARNER CHILCOTT PLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d228756dsc13d.htm SC 13D 105344
2 EX-1 d228756dex1.htm EX-1 5502
3 EX-3 d228756dex3.htm EX-3 160062
4 EX-4 d228756dex4.htm EX-4 3229
  Complete submission text file 0001193125-16-675312.txt   276052
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-55457 | Film No.: 161815123
SIC: 2834 Pharmaceutical Preparations

Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filed by) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations